
News|Podcasts|March 21, 2024
Phosgene at Valsynthese: An Atom-Economic Reagent That Demonstrates Exceptional Versatility
Author(s)Valsynthese
Dr. Luca Mantilli, R&D chemist at Valsynthese, the fine chemical unit of the Société Suisse des Explosifs Group (SSE), will guide you through the journey that Valsynthese as CDMO has done in phosgenation. The advantages and synthetic possibilities of phosgene, an extremely versatile reagent, will be highlighted with respect to other alternatives, same as the safety measures needed when working with such hazardous building blocks.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
2
CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor
3
Is Pharma Solving the Right Problem with its Data Transformation Efforts?
4
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
5



